Skip to main content
AZN logo
AZN
(NYSE)
AstraZeneca PLC
$156.94-- (--)
Loading... - Market loading

AstraZeneca (AZN) Stock Price & Financial Analysis

AstraZeneca Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$156.74 - $159.13
52-Week High$212.71
52-Week Low$72.90
Open$158.31
Volume3.87M
Average Volume (3M)3.93M
Market Cap244.83B
Shares Outstanding1.56B
P/E Ratio (TTM)23.44
Forward P/E18.72
Price to Sales (P/S)3.99
Price to Book (P/B)4.87
EV/EBITDA13.26
Revenue (TTM)61.37B
Net Income (TTM)10.45B
Free Cash Flow (TTM)8.39B
EPS (TTM)$6.69
Profit Margin17.02%
Operating Margin22.77%
Return on Equity (ROE)20.77%
Debt to Equity0.59
50-Day MA$167.85
200-Day MA$181.66
52-Week Change93.23%
Annual Dividend$7.46
Dividend Yield4.76%
Payout Ratio111.57%
Last Dividend Ex-DateMar 23, 2027

Frequently Asked Questions About AstraZeneca

What is the current stock price for AZN?

As of the latest trading session, AZN stock trades at $156.94. The 52-week range is $72.90–$212.71, with a day range of $156.74–$159.13.

What is the P/E ratio for AZN?

AstraZeneca's trailing P/E ratio is 23.4, meaning investors pay $23.4 for every $1 of annual earnings. The forward P/E is 18.7, reflecting analyst expectations for future earnings. AstraZeneca operates in the Healthcare sector.

Does AZN pay dividends?

Yes, AstraZeneca pays a 4.76% annual dividend yield ($7.46 per share). The payout ratio is 111.6%. The last ex-dividend date was 2027-03-23.

What do analysts recommend for AZN?

Based on 30 analysts, the consensus for AZN is Buy.

What is the market cap of AZN?

AstraZeneca's market capitalization is $244.83B, classifying it as a mega-cap company. AstraZeneca operates in the Healthcare sector within the Drug Manufacturers - General industry.